Meng Wang
Human Resources Officer at BOSHIWA INTERNATIONAL HOLDING LIMITED
Meng Wang active positions
Companies | Position | Start | End |
---|---|---|---|
BOSHIWA INTERNATIONAL HOLDING LIMITED | Human Resources Officer | 11/10/2010 | - |
Career history of Meng Wang
Former positions of Meng Wang
Companies | Position | Start | End |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Human Resources Officer | 01/10/2008 | 01/10/2008 |
Shanghai Sifang Boiler Works | Human Resources Officer | 01/07/2005 | 01/07/2005 |
Statistics
International
Hong Kong | 3 |
China | 2 |
Operational
Human Resources Officer | 3 |
Sectoral
Distribution Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Boshiwa International Holdings Ltd.
Boshiwa International Holdings Ltd. Wholesale DistributorsDistribution Services Boshiwa International Holdings Ltd. engages in the design, sourcing, and marketing of children's products. Its brands include Boshiwa, Baby2 and Dr. Frog, and licensed brands such as Harry Potter, Prince of Tennis, NBA, Barcelona, Juventus, Manchester United, Bob the Builder, and Thomas and Friends. The company was founded in 1997 and is headquartered in Hong Kong. | Distribution Services |
Shanghai Sifang Boiler Works | |
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
- Stock Market
- Insiders
- Meng Wang
- Experience